Business Context and Reporting Period
This Form 8-K is filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on May 3, 2017. The filing announces financial and operating results for the quarter ended March 31, 2017 (First Quarter 2017). The registrant is incorporated in California and operates from Sylmar, California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It serves solely as a notification that the Q1 2017 results have been announced and a press release has been issued.
Guidance, Outlook, and Risks
- Conference Call: The company conducted a conference call on May 3, 2017, to discuss results. A replay was available for 30 days.
- Forward-Looking Statements: The filing includes a standard disclaimer that statements made during the teleconference, other than historical financial information, are forward-looking. These are based on reasonable assumptions but are not guarantees of future performance.
- Disclaimer: The company disclaims any obligation to update or revise forward-looking statements except as required by law.
Investor Verification Checklist
- Verify the specific Q1 2017 financial figures (revenue, net loss, cash position) in the attached Exhibit 99.1 Press Release.
- Confirm the company name is Second Sight Medical Products, Inc. (the input metadata incorrectly listed Vivani Medical, Inc.).
- Review the conference call replay or transcript for management commentary on product development and regulatory milestones.
- Check subsequent filings for any updates to the forward-looking statements made on May 3, 2017.